ORTEXORTEX News

Articles

Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.

Market Commentary — 7990 total

Market Commentary

Banks and Beverages Dominate This Week

Today brings the first earnings of the week. LEVI reports Q2 2026 results after the close. PepsiCo drops its pre-recorded Q2 call tonight. Enerpac Tool Group and AZZ Inc. both report today as well. Tomorrow, Northern…

1 min read
Market Commentary

Payments Sector Draws Fresh Analyst Fire

Analysts reshuffled their views across the payments and fintech space on July 8, with a wave of new recommendations and target price moves hitting several major names. MSCI led the upgrades. The index data giant saw…

1 min read
Market Commentary

Bears Pile In: Chewy, Honeywell, CoreWeave In Focus

Short sellers turned aggressive this week. Data as of July 6 shows notable increases across several names. Chewy leads the pack. SI hit 72.4% of free float — up 3.3 percentage points in seven days. That is one of the…

1 min read
Market Commentary

Markets Digest M&A, AI Risks, and Earnings Countdown

Infrastructure dealmaking grabbed attention today. MasTec agreed to buy Electrical Specialists for roughly $1.65 billion. The move extends MasTec's reach in electrical contracting. The deal signals continued appetite…

1 min read
Market Commentary

Banks, Denim, and Delta: Big Week Ahead

The week kicks off today with several confirmed earnings releases. LEVI reports Q2 2026 results after the close on Tuesday, July 8. The denim giant faces pressure from tariff-driven cost increases. PEP posts a…

1 min read
Market Commentary

Wall Street Cuts CrowdStrike Target Hard

Stifel analyst Adam Borg slashed his price target on CRWD from $790 to $220. That is a 72% cut. He kept a Buy rating, but the implied upside dropped sharply. CrowdStrike trades at a $203 billion market cap. Short…

1 min read
Market Commentary

Executives Cash Out While One Biotech CEO Bets Big

Insider selling dominated filings over the past two weeks. The trend spans tech, retail, and aerospace. AST SpaceMobile CEO and founder Abel Avellan filed on June 23. He sold 2.5 million shares worth $146.7M at $58.68.…

1 min read
Market Commentary

Bears, Banks, and Biotech Drive Monday's Action

Short sellers are piling into vulnerable names. Chewy remains the most heavily shorted mid-cap in the US. Short interest sits at 72.4% of free float. Sable Offshore saw the week's biggest jump — SI surged 7.7…

1 min read
Market Commentary

Big Banks Dominate This Week's Calendar

Today brings the first action. EPAC — Enerpac Tool Group — reports Q3 2026 results this afternoon. Tomorrow, Tuesday, gets busy. LEVI reports Q2 results after the close. Denim demand and margin trends are in focus. PEP…

1 min read
Market Commentary

RBC Sweeps Biotech; Erste Cuts Broadcom

RBC Capital's Brian Abrahams published a wave of biotech calls on Monday. He raised his target on VRTX to $570 from $543, keeping a Buy rating. He also lifted BIIB to $242 from $227 on a Buy. The two upgrades came…

1 min read
Market Commentary

Execs Buy and Sell in Waves

Insider filings this month reveal a sharp split between bold buyers and heavy sellers across US markets. SMMT Chairman and CEO Robert Duggan filed a $50M purchase of Summit Therapeutics shares in June. He bought 3.8…

1 min read
Market Commentary

Biotech Bets, Bank Earnings, and a Fed Signal

Fed Governor Williams spoke this morning and struck a calm tone. He said monetary policy is "well positioned" and risks are balanced. He flagged that inflation remains elevated but energy price declines should help.…

1 min read
Market Commentary

Put-Call Spike Flags Hedge Demand in Biotech

EXEL is generating the loudest options signal today. The Exelixis put-call ratio hit 1.33. That is 4.1 standard deviations above its 20-day mean of 0.65. Traders are aggressively buying downside protection. Short…

1 min read
Market Commentary

Big Banks Line Up for Q2 Earnings

The earnings calendar heats up this week. Several high-profile names report across Tuesday through Friday. Today (Tuesday, July 7): EPAC — Enerpac Tool Group — kicks off with Q3 2026 results after the close. Tomorrow…

1 min read
Market Commentary

Analysts Boost Financials, Brokerages, Biotech

Wall Street lifted targets across multiple sectors on Monday. The upgrades were broad — banks, brokerages, and biotech all moved higher. HOOD led the pack. The consensus target price rose to $106.02 from $105.46.…

1 min read
Market Commentary

Execs Cash Out as H&M Founder Buys Big

Insiders across multiple sectors filed notable trades last week. The biggest story cuts both ways — selling dominated, but one founder made a striking bet on his own stock. H&M patriarch backs his brand. Stefan…

1 min read
Market Commentary

Bears Circle Chewy, Sable Offshore Shorted Hard

Short sellers made bold moves in several names this week. Chewy leads the action — SI hit 72.4% of free float, up 3.3 percentage points in seven days. Bears are not letting up on the pet retailer despite its mid-cap…

1 min read
Market Commentary

Earnings Week Sparks Unusual Options Signals

Earnings season opens this week with options traders positioning across several high-profile names ahead of key reports. DAL kicks things off Tuesday. Short interest sits at just 3.5% of free float. That low bearish…

1 min read
Market Commentary

Earnings Kickoff: Pepsi, Delta, Levi in Focus

The corporate earnings season shifts into gear this week. Three household names report results in the next four days, with no significant IPOs on the calendar. Today — Tuesday, July 8 Levi Strauss posts Q2 2026 results…

1 min read